Business Description
bluebird bio Inc
NAICS : 325414
SIC : 2836
ISIN : US09609G1004
Compare
Compare
Traded in other countries / regions
BLE.GermanyBLUE.Mexico0HOH.UKBLUE.USA IPO Date
2013-06-19Description
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.16 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.77 | |||||
| Debt-to-EBITDA | -1.13 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -7.5 | |||||
| Beneish M-Score | 15.32 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 29.1 | |||||
| 3-Year EPS without NRI Growth Rate | 30.4 | |||||
| 3-Year FCF Growth Rate | 26.2 | |||||
| 3-Year Book Growth Rate | -53.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.72 | |||||
| 9-Day RSI | 47.16 | |||||
| 14-Day RSI | 46.28 | |||||
| 6-1 Month Momentum % | -51.47 | |||||
| 12-1 Month Momentum % | 33.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.03 | |||||
| Quick Ratio | 3 | |||||
| Cash Ratio | 2.75 | |||||
| Days Inventory | 270.38 | |||||
| Days Sales Outstanding | 1101.48 | |||||
| Days Payable | 1649.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.4 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -27.47 | |||||
| Operating Margin % | -6105.58 | |||||
| Net Margin % | -3053.69 | |||||
| ROE % | -53.41 | |||||
| ROA % | -21.75 | |||||
| ROIC % | -61.15 | |||||
| ROC (Joel Greenblatt) % | -94.67 | |||||
| ROCE % | -56.76 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 78.91 | |||||
| PB Ratio | 1.09 | |||||
| Price-to-Tangible-Book | 1.12 | |||||
| EV-to-EBIT | -1.39 | |||||
| EV-to-EBITDA | -1.42 | |||||
| EV-to-Revenue | 84.63 | |||||
| EV-to-Forward-Revenue | 10.04 | |||||
| EV-to-FCF | -1.04 | |||||
| Price-to-Net-Current-Asset-Value | 30.25 | |||||
| Earnings Yield (Greenblatt) % | -71.94 |
Balance Sheet Breakdown
Cashflow Statement Breakdown
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BLUE
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
bluebird bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4.034 | ||
| EPS (TTM) ($) | -1.71 | ||
| Beta | -0.19 | ||
| Volatility % | 88.96 | ||
| 14-Day RSI | 46.28 | ||
| 14-Day ATR ($) | 0.30759 | ||
| 20-Day SMA ($) | 3.9035 | ||
| 12-1 Month Momentum % | 33.77 | ||
| 52-Week Range ($) | 2.78 - 8.58 | ||
| Shares Outstanding (Mil) | 106.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
bluebird bio Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
bluebird bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
bluebird bio Inc Frequently Asked Questions
What is bluebird bio Inc(BLUE)'s stock price today?
The current price of BLUE is $3.63. The 52 week high of BLUE is $8.58 and 52 week low is $2.78.
When is next earnings date of bluebird bio Inc(BLUE)?
The next earnings date of bluebird bio Inc(BLUE) is 2023-08-04 Est..
Does bluebird bio Inc(BLUE) pay dividends? If so, how much?
bluebird bio Inc(BLUE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers